Efficacy matters: broadening complement inhibition in COVID-19 - Authors' reply
Lancet Rheumatol
.
2021 Feb;3(2):e95-e96.
doi: 10.1016/S2665-9913(20)30424-0.
Epub 2020 Dec 14.
Authors
Alexander P J Vlaar
1
,
Sanne de Bruin
1
,
Matthijs C Brouwer
2
,
Diederik van de Beek
2
Affiliations
1
Department of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam 1100DD, Netherlands.
2
Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam 1100DD, Netherlands.
PMID:
33521673
PMCID:
PMC7834467
DOI:
10.1016/S2665-9913(20)30424-0
No abstract available